Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 3.58 Delayed Data As of 3:58pm ET |  -0.08 / -2.19%Today’s Change | 1.90 Today|||52-Week Range 4.70 | +40.67% Year-to-Date |
Institutional investors control 48.19% of the outstanding shares in NLTX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $304.5 thousand shares.
| Other institutional | 45.14% |
| Mutual fund holders | 3.05% |
| Individual stakeholders | 20.61% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 10/05/2023 | BAKER BROS. ADVISORS LP Bought 593.1 Thousand shares of Neoleukin Therapeutics In... |
| 9/30/2023 | ADAGE CAPITAL MANAGEMENT LP Bought 310.0 Thousand shares of Neoleukin Therapeutics In... |
| 9/30/2023 | NANTAHALA CAPITAL MANAGEMENT LLC Bought 300.0 Thousand shares of Neoleukin Therapeutics In... |
Top 10 Owners of Neoleukin Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 20.61% | 1,814,516 | 6,133,064 | +593,102 | +48.56% |
| Redmile Group LLC | 6.62% | 582,443 | 1,968,657 | -3 | -0.00% |
| Adage Capital Management LP | 3.52% | 310,000 | 1,047,800 | +310,000 | -- |
| Nantahala Capital Management LLC | 3.41% | 299,999 | 1,013,997 | +299,999 | -- |
| Bank of America, NA (Private Bank... | 2.62% | 230,491 | 779,060 | -1 | -0.00% |
| The Vanguard Group, Inc. | 2.26% | 198,761 | 671,812 | -623 | -0.31% |
| Renaissance Technologies LLC | 1.86% | 163,447 | 552,451 | -23,998 | -12.80% |
| BML Capital Management LLC | 1.12% | 98,664 | 333,484 | +93,914 | +1,977.14% |
| BlackRock Fund Advisors | 1.06% | 93,355 | 315,540 | -3 | -0.00% |
| Morgan Stanley & Co. LLC | 0.75% | 66,399 | 224,429 | -53,741 | -44.73% |
Top 10 Mutual Funds Holding Neoleukin Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF | 1.12% | 98,708 | 333,633 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 1.09% | 95,767 | 323,692 | 0 | 0.00% |
| Fidelity Extended Market Index Fu... | 0.42% | 36,986 | 125,013 | +2,624 | +7.64% |
| Fidelity Total Market Index Fund | 0.11% | 9,649 | 32,614 | -1 | -0.01% |
| Fidelity Series Total Market Inde... | 0.08% | 7,393 | 24,988 | -1 | -0.01% |
| Fidelity Nasdaq Composite Index F... | 0.05% | 4,505 | 15,227 | -1 | -0.02% |
| Vanguard Institutional Total Stoc... | 0.05% | 4,286 | 14,487 | -622 | -12.67% |
| JNL/Mellon Healthcare Sector Fund | 0.04% | 3,406 | 11,512 | 0 | 0.00% |
| Vanguard Invt. Fds. ICVC - US Equ... | 0.03% | 2,778 | 9,390 | 0 | 0.00% |
| Vifag 2002, SICAV | 0.02% | 1,999 | 6,757 | +5 | +0.25% |